The Business Times
business-time-50

QT Vascular enrols first patients for Chocolate Touch study

google-preferred-sourceAdd BT as a preferred source
Published Tue, May 19, 2015 · 09:50 PM

Singapore

CATALIST-LISTED healthcare company QT Vascular has announced that it has enrolled the first 11 patients in its First-In-Human (FIH) study of its novel Chocolate Touch PTCA (Coronary Drug Coated Chocolate) in the Dominican Republic.

In a filing to the Singapore Exchange on Tuesday, the group said it is working closely with local and United States physicians on the study, which will evaluate the clinical utility of the Chocolate Touch PTCA for the treatment of de novo coronary lesions.

QT Vascular

TRENDING NOW

Goh is DBS’ first group chief operating officer.

DBS COO’s most important tip for AI transformation: Lead with ‘why’

The Vietnamese economy has long relied heavily on bank lending, straining commercial banks as they shoulder the bulk of the financing needed by companies and large infrastructure projects.

Vietnam seeks US$76 billion a year from capital markets to ease reliance on banks

Under the Philippines’ new policy, up to four EV models will be provided with as much as 15 billion pesos each in fiscal support, in the form of tax payment certificates.

Too little, too late? Manila’s billion-dollar bid to ignite its sputtering EV industry

The 302-unit Cape Royale, completed in 2013, has been the last major new condominium development in Sentosa Cove. 

Two-thirds of Sentosa Cove resales in the red, with average loss topping S$1 million since 2023

Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More